30th Apr 2021 14:30
Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 400,000 shares via Vulpes Life Sciences Fund at 20.40 pence, worth about GBP81,600, on Thursday. Vulpes now has 116.6 million shares, a 14.3% stake.
Current stock price: 22.10p, up 7.3% on Friday
Year-to-date change: up 58%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Scancell Holdings